Symbol="EYPT"
AssetType="Common Stock"
Name="Eyepoint Pharmaceuticals Inc"
Description="EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts."
CIK="1314102"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="LABORATORY ANALYTICAL INSTRUMENTS"
Address="480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="490517000"
EBITDA="-84469000"
PERatio="None"
PEGRatio="None"
BookValue="1.669"
DividendPerShare="0"
DividendYield="0"
EPS="-2.58"
RevenuePerShareTTM="0.997"
ProfitMargin="-2.838"
OperatingMarginTTM="-2.297"
ReturnOnAssetsTTM="-0.262"
ReturnOnEquityTTM="-1.016"
RevenueTTM="37333000"
GrossProfitTTM="26948000"
DilutedEPSTTM="-2.58"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.213"
AnalystTargetPrice="31.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.154"
PriceToBookRatio="0.727"
EVToRevenue="0.112"
EVToEBITDA="0.162"
Beta="1.297"
num_52WeekHigh="14.58"
num_52WeekLow="2.19"
num_50DayMovingAverage="10.1"
num_200DayMovingAverage="5.73"
SharesOutstanding="34301900"
DividendDate="2020-12-09"
ExDividendDate="None"
symbol="EYPT"
open="14.25"
high="15.63"
low="14.15"
price="15.36"
volume="747667.00"
latest_trading_day="2023-08-21"
previous_close="14.30"
change="1.06"
change_percent="7.4126%"
aroon_positive_momentum_days="86"
aroon_negative_momentum_days="0"
trend_strength="Strong Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="86"
Volume_recent_avg="815182"
Change_recent_avg="0.11"
Delta_recent_avg="0.78"
Variance_recent_avg="0.39"
Change_ratio_recent_avg="1.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="86"
Aroon_momentum_negative="14"
image_negative_thumbnail_id_1="111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_negative_thumbnail_id_2="1115"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0148.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="530"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_positive_thumbnail_id_1="650"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_positive_thumbnail_id_2="966"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0128.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
